Dolby Laboratories (NYSE:DLB – Get Free Report) had its price objective lowered by research analysts at Rosenblatt Securities from $85.00 to $80.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the electronics maker’s stock. Rosenblatt Securities‘s price objective suggests a potential upside of 30.87% from the company’s previous close.
Several other equities analysts also recently commented on the stock. Weiss Ratings upgraded shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, September 9th. Zacks Research upgraded shares of Dolby Laboratories from a “strong sell” rating to a “hold” rating in a research note on Friday. Finally, Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Dolby Laboratories currently has an average rating of “Moderate Buy” and a consensus price target of $85.00.
View Our Latest Analysis on Dolby Laboratories
Dolby Laboratories Trading Down 3.9%
NYSE:DLB opened at $61.13 on Monday. The stock has a 50 day simple moving average of $60.97 and a 200 day simple moving average of $59.43. The stock has a market cap of $5.73 billion, a P/E ratio of 26.01 and a beta of 0.79. Dolby Laboratories has a 1-year low of $48.26 and a 1-year high of $69.95.
Dolby Laboratories declared that its board has approved a share buyback program on Thursday, July 30th that authorizes the company to buy back $350 million in outstanding shares. This buyback authorization authorizes the electronics maker to reacquire up to 7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s management believes its stock is undervalued.
Insiders Place Their Bets
In other news, CAO Ryan Nicholson sold 1,183 shares of the company’s stock in a transaction on Tuesday, August 25th. The stock was sold at an average price of $65.28, for a total transaction of $77,226.24. Following the completion of the sale, the chief accounting officer directly owned 34,453 shares in the company, valued at approximately $2,249,091.84. This represents a 3.32% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP John D. Couling sold 7,667 shares of the stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $58.78, for a total value of $450,666.26. Following the sale, the senior vice president directly owned 166,803 shares in the company, valued at approximately $9,804,680.34. This trade represents a 4.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 16,517 shares of company stock worth $995,963. Corporate insiders own 37.93% of the company’s stock.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. State of Michigan Retirement System lifted its position in Dolby Laboratories by 1.4% during the first quarter. State of Michigan Retirement System now owns 14,700 shares of the electronics maker’s stock worth $883,000 after purchasing an additional 200 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al increased its holdings in Dolby Laboratories by 4.9% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 4,300 shares of the electronics maker’s stock valued at $253,000 after buying an additional 200 shares during the period. Frank Rimerman Advisors LLC increased its holdings in Dolby Laboratories by 2.7% in the 3rd quarter. Frank Rimerman Advisors LLC now owns 8,403 shares of the electronics maker’s stock valued at $494,000 after buying an additional 223 shares during the period. CX Institutional raised its position in shares of Dolby Laboratories by 2.7% in the 3rd quarter. CX Institutional now owns 13,074 shares of the electronics maker’s stock valued at $768,000 after buying an additional 347 shares in the last quarter. Finally, Sanctuary Advisors LLC raised its position in shares of Dolby Laboratories by 8.9% in the 1st quarter. Sanctuary Advisors LLC now owns 8,022 shares of the electronics maker’s stock valued at $482,000 after buying an additional 657 shares in the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc. develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video. The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.
See Also
- Five stocks we like better than Dolby Laboratories
- MongoDB’s Biggest Advantage May Be GitLab’s Biggest Weakness
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
